SIEMENS HEALTHINEERS ADR - SMMNY STOCK NEWS

Siemens eMobility announced the Ford Charge Station Pro, an innovative electric vehicle charger for the Ford F-150 Lightning, has received certification under the expanded UL 9741 standard. This charger, with a peak power of 19.2kW, is the first bidirectional-ready EV solution available at retail scale. The station enables Ford Intelligent Backup Power, allowing the F-150 Lightning to act as a power source during outages. Future firmware updates will enhance interaction with the grid, promoting sustainable and reliable home charging.

Siemens Healthineers announced the availability of the CLINITEST Rapid COVID-19 Antigen Self-Test in the U.S. after receiving FDA Emergency Use Authorization. The test provides accurate results in just 15 minutes and can be self-administered by individuals aged 14 and older. The company is supplying millions of tests to the U.S. federal government and various organizations, aiming to enhance COVID-19 testing accessibility during ongoing surges. The tests are also available for purchase online and in stores, including Amazon.com.

Siemens Healthineers has received FDA Emergency Use Authorization (EUA) for its CLINITEST Rapid COVID-19 Antigen Self-Test, allowing unsupervised self-testing for individuals aged 14 and over. The test provides results in just 15 minutes and is part of a nationwide retail distribution to meet increasing COVID-19 testing demands. The test has shown an accuracy with sensitivity at 86.5% and specificity at 99.3%, ensuring reliable results for users. The product is set to launch in January 2022, with production capabilities in the tens of millions per month.

Siemens Healthineers' ELF Test has been recognized as the top-performing biomarker in the NIMBLE study, as reported in a presentation at The Liver Meeting 2021. The ELF Test excelled in identifying fibrosis stages ≥2, with enhanced performance for stages ≥3 and 4. This recognition supports its potential to transform NASH clinical trials by reducing reliance on invasive liver biopsies. The NIMBLE project aims to validate non-invasive biomarkers for diagnosing NASH, impacting about 15 million people in the U.S. Successful regulatory qualification could revolutionize clinical trial methodologies.

Siemens Government Technologies has been awarded a contract over $1.78M by the FDA to implement an Advanced Digital Design and Manufacturing line as part of the FDA’s Advanced Manufacturing and Supply Chain programs. This partnership aims to enhance product development, increase manufacturing capacity, and improve product quality in the Lifesciences sector. The initiative will leverage Siemens Digital Industries’ software, facilitating the evaluation and adoption of advanced manufacturing processes, ultimately reducing supply chain shortages and accelerating responses to public health challenges.

Siemens Healthineers has received De Novo marketing authorization for the Enhanced Liver Fibrosis (ELF) Test, an innovative blood test for patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH). This test aids in assessing the risk of progression to cirrhosis and liver-related complications. The ELF Test, which was previously granted Breakthrough Device Designation in November 2018, offers a noninvasive, convenient, and reproducible solution for diagnosing advanced liver conditions.

Siemens is committing to expand its U.S. manufacturing operations to support electric vehicle (EV) infrastructure, planning to produce over 1 million EV chargers in the next four years. This investment aligns with the $1 trillion bipartisan infrastructure bill and aims to create 100 jobs. Siemens will unveil a new facility for AC charger manufacturing in early 2022, complementing its existing operations in North Carolina. The company emphasizes enhancing U.S. infrastructure and job growth in electrification.

Siemens Healthineers has launched WeScan, a remote MRI examination service utilizing TeamViewer's technology to address radiology staff shortages. This service connects healthcare providers with skilled remote technologists who operate MRI scanners using Siemens' syngo Virtual Cockpit. The partnership highlights secure data transmission and high-performance access, crucial for healthcare. WeScan aims to enhance device utilization and patient access while responding to the increasing demand for remote healthcare solutions.

Varian announced CEO Dow Wilson's retirement after 16 years, coinciding with its merger with Siemens Healthineers. Chris Toth, current President and COO, will succeed him as the CEO of Varian's segment within Siemens. Wilson will assist as a special advisor post-transition. Under Wilson's leadership since 2012, Varian achieved double-digit growth and expanded its market presence in cancer care, creating 4,000 jobs. The merger is anticipated to complete in H1 2021, furthering Varian's vision for innovative cancer treatment.